OPTIMAL 2-STAGE DESIGNS FOR PHASE-II CLINICAL-TRIALS

被引：2983

作者：

SIMON, R

机构：

来源：

CONTROLLED CLINICAL TRIALS | 1989年 / 10卷 / 01期

关键词：

D O I：

10.1016/0197-2456(89)90015-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：1 / 10

页数：10

相关论文

共 15 条

[1] CHANG MN, 1986, CONTROL CLIN TRIALS, V7, P18, DOI 10.1016/0197-2456(86)90004-8
[2] DESIGNS FOR GROUP SEQUENTIAL PHASE-II CLINICAL-TRIALS
CHANG, MN
THERNEAU, TM
WIEAND, HS
CHA, SS
[J]. BIOMETRICS, 1987, 43 (04) : 865 - 874
[3] 2-STAGE PLANS COMPARED WITH FIXED-SAMPLE SIZE AND WALD SPRT PLANS
COLTON, T
MCPHERSON, K
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1976, 71 (353) : 80 - 86
[4] STOPPING GUIDELINES VS STOPPING RULES - A PRACTITIONERS POINT OF VIEW
DEMETS, DL
[J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1984, 13 (19) : 2395 - 2417
[5] ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS
FLEMING, TR
[J]. BIOMETRICS, 1982, 38 (01) : 143 - 151
[6] DETERMINATION OF NUMBER OF PATIENTS REQUIRED IN A PRELIMINARY AND A FOLLOW-UP TRIAL OF A NEW CHEMOTHERAPEUTIC AGENT
GEHAN, EA
[J]. JOURNAL OF CHRONIC DISEASES, 1961, 13 (04): : 346 - &
[7] PREDICTIVE PROBABILITY EARLY TERMINATION PLANS FOR PHASE-II CLINICAL-TRIALS
HERSON, J
[J]. BIOMETRICS, 1979, 35 (04) : 775 - 783
[8] EFFICIENT GROUP SEQUENTIAL-TESTS WITH UNPREDICTABLE GROUP SIZES
JENNISON, C
[J]. BIOMETRIKA, 1987, 74 (01) : 155 - 165
[9] JENNISON C, 1983, TECHNOMETRICS, V25, P49
[10] LEE YJ, 1979, CANCER TREAT REP, V63, P1721